{"id":"https://openalex.org/W2896058045","doi":"https://doi.org/10.1158/2326-6074.tumimm17-ia07","title":"Abstract IA07: Genetic engineering of therapeutic T cells using synthetic nanoparticles","display_name":"Abstract IA07: Genetic engineering of therapeutic T cells using synthetic nanoparticles","publication_year":2018,"publication_date":"2018-09-01","ids":{"openalex":"https://openalex.org/W2896058045","doi":"https://doi.org/10.1158/2326-6074.tumimm17-ia07","mag":"2896058045"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6074.tumimm17-ia07","doi":"https://doi.org/10.1158/2326-6074.tumimm17-ia07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm17-ia07","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075253163","display_name":"Howell F. Moffett","orcid":"https://orcid.org/0000-0002-7799-1688","observed_orcids":["https://orcid.org/0000-0002-7799-1688"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howell F. Moffett","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019550608","display_name":"Tyrel T. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tyrel T. Smith","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063788144","display_name":"Matthias T. Stephan","orcid":"https://orcid.org/0000-0001-8310-0100","observed_orcids":["https://orcid.org/0000-0001-8310-0100"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthias T. Stephan","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210089486"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"9_Supplement","first_page":"IA07","last_page":"IA07"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.6869999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.6869999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.1761000007390976,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.08590000122785568,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-engineering","display_name":"T cell engineering","score":0.49000000953674316},{"id":"https://openalex.org/keywords/synthetic-nanoparticles","display_name":"synthetic nanoparticles","score":0.9240000247955322},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.8399999737739563},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.503000020980835},{"id":"https://openalex.org/keywords/polymeric-nanocarriers","display_name":"polymeric nanocarriers","score":0.9160000085830688},{"id":"https://openalex.org/keywords/cellular-immunotherapy","display_name":"cellular immunotherapy","score":0.6639999747276306},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6425285935401917},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5635034441947937},{"id":"https://openalex.org/C186852380","wikidata":"https://www.wikidata.org/wiki/Q1142521","display_name":"Electroporation","level":3,"score":0.530480682849884},{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.5127962231636047},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5124988555908203},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.41784876585006714},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34888601303100586},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3351736068725586},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33433470129966736},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33414310216903687},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2576180398464203},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23581057786941528},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.1306249499320984},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12193647027015686},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.11185234785079956}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6074.tumimm17-ia07","doi":"https://doi.org/10.1158/2326-6074.tumimm17-ia07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm17-ia07","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2607356458","https://openalex.org/W2980205898","https://openalex.org/W6939366286","https://openalex.org/W4393096594","https://openalex.org/W2610087688","https://openalex.org/W4200147949","https://openalex.org/W3107786127","https://openalex.org/W4323037099","https://openalex.org/W2625615732","https://openalex.org/W3005106351"],"abstract_inverted_index":{"Abstract":[0],"Despite":[1],"the":[2,13,21,76,128,136,173,201,265,298],"obvious":[3],"advantages":[4,151],"afforded":[5],"by":[6,50,96],"targeted":[7,101,118],"T-cell":[8],"cancer":[9],"therapies":[10],"(compared":[11],"with":[12,99,213],"blunt":[14],"instruments":[15],"of":[16,39,111,130,138,176,267,272,287,297],"chemotherapy,":[17],"radiotherapy,":[18],"and":[19,23,55,65,122,162,168,239,246,305],"surgery),":[20],"complexity":[22],"costs":[24],"involved":[25],"in":[26,42,91,231,269],"producing":[27],"genetically":[28,86],"modified":[29],"lymphocytes":[30],"remain":[31],"major":[32,124],"obstacles":[33],"to":[34,46,58,85,108,117,140,156,237],"their":[35],"implementation":[36],"as":[37],"standard":[38],"care.":[40],"Work":[41],"our":[43,186],"laboratory":[44,204],"aims":[45],"obviate":[47],"these":[48,113],"problems":[49],"integrating":[51],"materials":[52],"science,":[53],"immunology,":[54],"gene":[56,133],"therapy":[57,134],"make":[59],"cellular":[60],"immunotherapy":[61],"more":[62],"effective,":[63],"practical,":[64,255],"widespread.":[66],"In":[67,75,172],"this":[68],"talk,":[69],"I":[70,79,179],"will":[71,80,180],"highlight":[72],"two":[73],"examples:":[74],"first":[77],"segment,":[78],"describe":[81],"a":[82,100,109,182,254,270],"new":[83,183],"strategy":[84],"imprint":[87],"therapeutically":[88],"desirable":[89],"phenotypes":[90],"cultured":[92],"T":[93,119,198,229,289],"cells,":[94,112],"simply":[95],"mixing":[97],"them":[98],"mRNA-carrying":[102],"nanoreagent.":[103],"When":[104],"they":[105,210],"are":[106,211,235,240],"added":[107],"culture":[110],"engineered":[114],"nanoparticles":[115,234,293],"bind":[116],"cell":[120],"populations":[121],"induce":[123],"biologic":[125],"effects":[126],"on":[127,302],"basis":[129],"transient":[131],"\u201chit-and-run\u201d":[132],"without":[135,200],"necessity":[137],"resorting":[139],"complicated":[141],"protocols":[142],"or":[143],"complex":[144],"ancillary":[145],"equipment.":[146],"Our":[147],"approach":[148],"provides":[149],"significant":[150],"over":[152],"those":[153],"currently":[154],"used":[155],"create":[157],"cytoreagents":[158],"(i.e.,":[159],"viral":[160],"transfection":[161],"electroporation),":[163],"which":[164,242],"require":[165],"specialized":[166],"equipment":[167],"demanding":[169],"production":[170],"steps.":[171],"second":[174],"part":[175],"my":[177],"presentation,":[178],"introduce":[181],"injectable":[184],"reagent":[185],"group":[187],"developed":[188],"that":[189,190,259],"can":[191,218,260],"quickly":[192],"program":[193],"tumor-recognizing":[194],"capabilities":[195],"into":[196,227],"circulating":[197],"cells":[199,230,290],"need":[202],"for":[203],"manipulations.":[205],"We":[206],"demonstrate":[207],"that,":[208],"once":[209],"adapted":[212],"lymphocyte-targeting":[214],"ligands,":[215],"polymeric":[216],"nanocarriers":[217],"selectively":[219],"deliver":[220],"leukemia-specific":[221],"chimeric":[222],"antigen":[223],"receptor":[224],"(CAR)":[225],"genes":[226],"host":[228],"situ.":[232],"These":[233],"easy":[236],"manufacture":[238],"stable,":[241],"simplifies":[243],"long-term":[244],"storage":[245],"reduces":[247],"cost.":[248],"This":[249],"technology":[250],"may":[251],"therefore":[252],"provide":[253],"broadly":[256],"applicable":[257],"treatment":[258],"generate":[261],"antitumor":[262],"immunity":[263],"at":[264],"time":[266],"diagnosis":[268],"variety":[271],"settings.":[273],"Citation":[274],"Format:":[275],"Howell":[276],"F.":[277],"Moffett,":[278],"Tyrel":[279],"T.":[280,283],"Smith,":[281],"Matthias":[282],"Stephan.":[284],"Genetic":[285],"engineering":[286],"therapeutic":[288],"using":[291],"synthetic":[292],"[abstract].":[294],"In:":[295],"Proceedings":[296],"AACR":[299],"Special":[300],"Conference":[301],"Tumor":[303],"Immunology":[304],"Immunotherapy;":[306],"2017":[307],"Oct":[308],"1-4;":[309],"Boston,":[310],"MA.":[311],"Philadelphia":[312],"(PA):":[313],"AACR;":[314],"Cancer":[315],"Immunol":[316],"Res":[317],"2018;6(9":[318],"Suppl):Abstract":[319],"nr":[320],"IA07.":[321]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-10-26T00:00:00"}